1.
HIV-1 group P infection: towards a dead-end infection?
by Alessandri-Gradt, Elodie
AIDS (London), 2018-06-19, Vol.32 (10), p.1317-1322
2.
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model
by Yant, Stephen R
Nature medicine, 2019-09, Vol.25 (9), p.1377-1384
3.
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
by Moore, Penny L
Nature medicine, 2012-11, Vol.18 (11), p.1688-1692
4.
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
by Hessell, Ann J
Nature medicine, 2016-04, Vol.22 (4), p.362-368
5.
COMPASS identifies T-cell subsets correlated with clinical outcomes
by Lin, Lin
Nature biotechnology, 2015-06, Vol.33 (6), p.610-616
6.
Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease
by Tebit, Denis M, PhD
The Lancet infectious diseases, 2011, Vol.11 (1), p.45-56
7.
Monocyte chemoattractant protein-1 (MCP-1): an overview
by Deshmane, Satish L
Journal of interferon & cytokine research, 2009-06, Vol.29 (6), p.313-326
8.
Global epidemiology of HIV infection in men who have sex with men
by Beyrer, Chris, Prof
The Lancet (British edition), 2012, Vol.380 (9839), p.367-377
9.
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
by Bar-On, Yotam
Nature medicine, 2018-11, Vol.24 (11), p.1701-1707
10.
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
by Girard, Marc P
Vaccine, 2011, Vol.29 (37), p.6191-6218
11.
Pathogenesis of HIV infection: what the virus spares is as important as what it destroys
by Grossman, Zvi
Nature medicine, 2006-03, Vol.12 (3), p.289-295
12.
Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus
by IMAMICHI, Hiromi
AIDS (London), 2014, Vol.28 (8), p.1091-1099
13.
MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins
by Tada, Takuya
Nature medicine, 2015-12, Vol.21 (12), p.1502-1507
14.
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure
by CHUN, Tae-Wook
AIDS (London), 2012, Vol.26 (10), p.1261-1268
15.
Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review
by Barth, Roos E, Dr
The Lancet infectious diseases, 2010, Vol.10 (3), p.155-166
16.
Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection
by Kazer, Samuel W
Nature medicine, 2020-04, Vol.26 (4), p.511-518
17.
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
by Simon, Viviana
The Lancet (British edition), 2006, Vol.368 (9534), p.489-504
18.
Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo
by Maldini, Colby R
Nature medicine, 2020-11, Vol.26 (11), p.1776-1787
19.
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
by Berger, Edward A
Annual review of immunology, 1999-04, Vol.17 (1), p.657-700
20.
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
by Matthews, Randolph P
Nature medicine, 2021-10, Vol.27 (10), p.1712-1717
